Capsugel Announces Expansion at Quakertown Facility
PTSM: Pharmaceutical Technology Sourcing and Management
Capsugel is expanding the facility to meet demand for micronization services for clinical and commercial manufacturing.
On Sept. 7, 2016, Capsugel announced that it will be expanding its Quakertown, PA facility to meet demand for micronization services for clinical and commercial manufacturing. The expansion will double the size of its current pilot-scale capacity for clinical-trial quantities and increase the number of suites for commercial manufacturing.
The Quakertown facility, which Capsugel acquired as part of its purchase of Xcelience and Powdersize in January 2016, operates as a full-service provider of particle-size reduction and particle-size control/classification technologies for pharmaceutical customers. The acquisition expanded the company’s suite of bioavailability tools aimed at improving the bioavailability of APIs with either dissolution or solubility challenges. In addition to enabling increased capacity, the added suites will include single-use containment technologies to accommodate potent and highly potent compounds. The new equipment and suites are scheduled to be operational by January 2017.
Source: Capsugel
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
